The role of FOXP3 in disease progression in colorectal cancer patients

28Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The transcription factor forkhead box P3 (FOXP3) has been identified as a marker of CD4+CD25+ regulatory T cells and is a key determinant of their immunosuppressive functions. FOXP3 has indeed been shown to limit antitumor immune responses during tumor progression. In addition, by expressing FOXP3, tumor cells may evade effector T-cell responses. © 2013 Landes Bioscience.

Author supplied keywords

Cite

CITATION STYLE

APA

Grimmig, T., Kim, M., Germer, C. T., Gasser, M., & Waaga-Gasser, A. M. (2013). The role of FOXP3 in disease progression in colorectal cancer patients. OncoImmunology, 2(6). https://doi.org/10.4161/onci.24521

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free